Skip to main content
. 2020 Apr 4;9(2):325–339. doi: 10.1007/s40121-020-00292-8
Combination therapy was independently associated with reduced odds of clinical failure in methicillin-resistant Staphylococcus aureus bloodstream infections.
The composite endpoint of clinical failure was driven by 60-day recurrence and persistent bacteremia but not 30-day mortality.
Time to bacterial clearance was shorter in patients managed with combination therapy compared to monotherapy.